RESEARCH HIGHLIGHTS

MOLECULAR PROFILING A double agent The factor NK2‑related Paediatric T cell acute lympho­ Cre to activate the expression of 1 (NKX2-1) is essential blastic leukaemia (T-ALL) is an one copy of an oncogenic Kras for normal lung development, and aggressive malignancy that is char‑ transgene and to delete Trp53 in LSL- previous work has indicated that the acterized by the presence of specific KrasG12D/+;Trp53flox/flox mice. Tracking amplification of NKX2-1 in a small genetic abnormalities; however, for genomic lentiviral integration sites subset of lung is oncogenic. 40% of cases the driving mutations enabled a comparison of expression Two recent reports describe diver‑ remain undiscovered. Writing in profiles between metastatic and non- gent roles for NKX2-1 in : Cancer Cell, Jules Meijerink and metastatic cells and revealed that in one context this transcription colleagues have uncovered a new Nkx2-1 is downregulated in advanced factor is oncogenic and in another it genomic profile that is associated lung adenocarcinomas. Reduced functions as a suppressor of tumour with the expression of NKX2-1. Nkx2-1 expression correlated with progression. Expression profiling and cytogenetic high-grade, poorly differentiated analysis of 117 samples from paedi‑ adenocarcinoma, whereas Nkx2-1‑ atric patients with T-ALL identified expressing tumours were well-differ‑ two mutually exclusive T-ALL entiated. Moreover, overexpression subtypes, neither of which possessed of Nkx2-1 was found to greatly limit known oncogenic alterations. One of the number of high-grade adeno­ these subtypes exhibited maturation carcinomas, and silencing of Nkx2-1 arrest at the CD1‑positive cortical expression in lung cancer cells either thymic stage and had high expression intravenously injected or intraspleni‑ levels of NKX2-1. Correspondingly, cally transplanted increased lung and molecular cytogenetic techniques, metastatic liver nodules, respectively. including chromatin conformation Furthermore, knockdown of Hmga2 capture on chip (4C) — a method — which is repressed by NKX2-1 — that robustly detects reciprocal in Nkx2-1‑negative cells significantly chromosomal rearrangements — in decreased metastatic seeding. this subgroup identified five NKX2-1 Thus, the dual role of NKX2-1 (or homologous NKX2-2) rearrange‑ proposed by these studies empha‑ ments in seven of 12 cases. Support sizes the importance of molecular for an oncogenic role for NKX2-1 in profiling and characterization across this study was provided by its ability not only malignancies, but also to transform fibroblast cells together their stages. with or RAS. Kira Anthony, Editor, NCI-Nature However, the function of NKX2-1 Pathway Interaction Database seems to be more complex than that of a simple oncogene, as a ORIGINAL RESEARCH PAPERS Homminga, I. et al. Integrated transcript and genome analyses recent Nature paper has indicated reveal NKX2‑1 and MEF2C as potential oncogenes that Nkx2-1 can hinder lung cancer in T cell acute lymphoblastic leukemia. Cancer progression in mice. Tyler Jacks Cell 19, 484–497 (2011) | Winslow, M. M. et al. Suppression of lung adenocarcinoma progression and colleagues induced lung cancer by Nkx2‑1. Nature 473, 101–104 (2011) using lentiviral vectors expressing

NATURE REVIEWS | CANCER VOLUME 11 | JUNE 2011 © 2011 Macmillan Publishers Limited. All rights reserved